APA

Jacquet E., Lardy-Cléaud A., Pistilli B., Franck S., Cottu P., Delaloge S., Debled M., Vanlemmens L., Leheurteur M., Guizard A. V., Laborde L., Uwer L., Jacot W., Berchery D., Desmoulins I., Ferrero J. M., Perrocheau G., Courtinard C., Brain E., Chabaud S., Robain M. & Bachelot T. (20190111). Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. : European journal of cancer (Oxford, England : 1990).

Chicago

Jacquet E, Lardy-Cléaud A, Pistilli B, Franck S, Cottu P, Delaloge S, Debled M, Vanlemmens L, Leheurteur M, Guizard A V, Laborde L, Uwer L, Jacot W, Berchery D, Desmoulins I, Ferrero J M, Perrocheau G, Courtinard C, Brain E, Chabaud S, Robain M and Bachelot T. 20190111. Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. : European journal of cancer (Oxford, England : 1990).

Harvard

Jacquet E., Lardy-Cléaud A., Pistilli B., Franck S., Cottu P., Delaloge S., Debled M., Vanlemmens L., Leheurteur M., Guizard A. V., Laborde L., Uwer L., Jacot W., Berchery D., Desmoulins I., Ferrero J. M., Perrocheau G., Courtinard C., Brain E., Chabaud S., Robain M. and Bachelot T. (20190111). Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. : European journal of cancer (Oxford, England : 1990).

MLA

Jacquet E, Lardy-Cléaud A, Pistilli B, Franck S, Cottu P, Delaloge S, Debled M, Vanlemmens L, Leheurteur M, Guizard A V, Laborde L, Uwer L, Jacot W, Berchery D, Desmoulins I, Ferrero J M, Perrocheau G, Courtinard C, Brain E, Chabaud S, Robain M and Bachelot T. Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. : European journal of cancer (Oxford, England : 1990). 20190111.